Microengineered environments for epithelial-mesenchymal interactions (SysCODE 7

$381,670RL1FY2011DENIH

Brigham And Women'S Hospital, Boston MA

Investigators

Linked publications & trials

Paper 30375196 Paper 29663706 Paper 29626550 Paper 29200661 Paper 27510763 Paper 27037064 Paper 26996755 Paper 26924450 Paper 26915715 Paper 26799457 Paper 26666585 Paper 26501166 Paper 26327819 Paper 26304467 Paper 26214188 Paper 25530795 Paper 25516556 Paper 25482315 Paper 25411576 Paper 25044366 Paper 24988275 Paper 24947233 Paper 24927679 Paper 24906345 Paper 24818770 Paper 24794894 Paper 24741694 Paper 24733776 Paper 24620821 Paper 24549115 Paper 24473466 Paper 24453182 Paper 24344625 Paper 24319406 Paper 24264728 Paper 24253194 Paper 24179675 Paper 24170301 Paper 24013352 Paper 23973391 Paper 23935392 Paper 23853426 Paper 23747008 Paper 23728018 Paper 23670944 Paper 23639533 Paper 23626908 Paper 23560817 Paper 23453201 Paper 23419055 Paper 23394067 Paper 23350771 Paper 23226295 Paper 23195284 Paper 23193099 Paper 23168222 Paper 23018132 Paper 22941804 Paper 22914562 Paper 22836944 Paper 22765012 Paper 22711442 Paper 22705446 Paper 22521491 Paper 22368689 Paper 22223475 Paper 22167009 Paper 22166590 Paper 22162397 Paper 22144036 Paper 22101755 Paper 22094245 Paper 21874065 Paper 21837312 Paper 21802723 Paper 21766872 Paper 21751069 Paper 21689062 Paper 21684595 Paper 21627163 Paper 21614380 Paper 21571364 Paper 21483937 Paper 21476591 Paper 21451238 Paper 21449596 Paper 21415929 Paper 21374805 Paper 21344866 Paper 21344063 Paper 21337336 Paper 21319297 Paper 21306293 Paper 21298801 Paper 21295165 Paper 21220962 Paper 21096824 Paper 21076185 Paper 20965560 Paper 20941801

Abstract

Diabetes and heart failure are diseases of enormous burden to Americans, and current therapies for these often-lethal diseases are clearly inadequate. The generation of organs suitable for transplantation offers tremendous potential to treat these types of diseases. The early development of over 20 mammalian organs involves the sequential, ordered exchange of signals between interacting epithelial and mesenchymal cell populations, resulting in their progressive differentiation. We hypothesize that this complex, dynamic regulatory network can be resolved by the integration of different scientific disciplines and used to design and build organ precursors or parts. As a part of the larger SysCODE consortium we will develop technologies that can be used to engineer the surrounding microenvironment. We propose to develop novel, three dimensional (3D) microscale constructs to be used as tools to study populations of interacting mesenchymal and epithelial cells . These microscale techniques will enable the biomimecry of the complex 3D structure of epithelial and mesenchymal cell interactions that occur in the embryonic in vivo environment. In vivo, the cellular environment is tightly regulated in 3D by interactions between cell-cell, cell-extracellular matrix (ECM) and cell-soluble factors. To effectively mimic mesenchymal and epithelial tissue we will engineer novel hydrogels embedded with cell types that resemble the cells native to these tissues. Addition features such as the basement membrane will also be engineered to fascilitate the movement of growth factors and environmental cues between the two types of tissue. This will all be accomplished through the successful completion of the following three Specific Aims: Aim 1: To develop biomimetic materials for engineering the cell-ECM interactions within 3D epithelial-mesenchymal constructs. Aim 2: To fabricate microscale constructs that can be used to study the interactions between epithelial and mesenchyme cell populations. Aim 3: To develop and validate a combinatorial approach to study microenvironmental factors in interacting epithelial and mesenchymal cell populations.

View original record on NIH RePORTER →